Skip to main content
Engraftment and survival following non-myeloablative allogeneic peripheral blood hematopoietic cell transplantation for malignant diseases is affected by CD8(+) T-cell dose. 46th Annual Meeting of the American-Society-of-Hematology Cao, T. M., Shizuru, J. A., Wong, R. M., Sheehan, K., Laport, G. G., Stockerl-Goldstein, K. E., JOHNSTON, L. J., Stuart, M. J., Brown, J. M., GRUMET, F. C., Negrin, R. S., Lowsky, R. AMER SOC HEMATOLOGY. 2004: 56A–56A

View details for Web of Science ID 000225127500186